JP2023550480A5 - - Google Patents
Info
- Publication number
- JP2023550480A5 JP2023550480A5 JP2023530809A JP2023530809A JP2023550480A5 JP 2023550480 A5 JP2023550480 A5 JP 2023550480A5 JP 2023530809 A JP2023530809 A JP 2023530809A JP 2023530809 A JP2023530809 A JP 2023530809A JP 2023550480 A5 JP2023550480 A5 JP 2023550480A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- hpv6
- vector
- polynucleotide according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063118222P | 2020-11-25 | 2020-11-25 | |
| US63/118,222 | 2020-11-25 | ||
| PCT/US2021/060605 WO2022115470A1 (en) | 2020-11-25 | 2021-11-23 | Human papilloma virus vaccines and uses of the same for hpv associated diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023550480A JP2023550480A (ja) | 2023-12-01 |
| JP2023550480A5 true JP2023550480A5 (enExample) | 2024-12-02 |
Family
ID=81754898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530809A Pending JP2023550480A (ja) | 2020-11-25 | 2021-11-23 | ヒト乳頭腫ウイルスワクチンおよびｈｐｖ関連疾患のための同ワクチンの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240173396A1 (enExample) |
| EP (1) | EP4251278A4 (enExample) |
| JP (1) | JP2023550480A (enExample) |
| KR (1) | KR20230113331A (enExample) |
| CN (1) | CN117203342A (enExample) |
| AU (1) | AU2021385551A1 (enExample) |
| CA (1) | CA3197920A1 (enExample) |
| IL (1) | IL303113A (enExample) |
| MX (1) | MX2023006038A (enExample) |
| WO (1) | WO2022115470A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026518240A (ja) * | 2023-05-22 | 2026-06-04 | プレシゲン，インコーポレイテッド | 再発性呼吸器乳頭腫症の処置のための新規アデノウイルスワクチン療法 |
| KR20260032470A (ko) * | 2023-05-22 | 2026-03-09 | 프레시전 인코포레이티드 | Hpv 백신 요법의 결과로 생성된 t 세포 수용체 및 이를 이용하여 환자를 치료하는 방법 |
| CN117965634B (zh) * | 2024-04-01 | 2024-07-12 | 北京唯源立康生物科技股份有限公司 | 一种hsv-1病毒载体及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPN443995A0 (en) * | 1995-07-27 | 1995-08-17 | Csl Limited | Papillomavirus polyprotein |
| US6225289B1 (en) | 1998-12-10 | 2001-05-01 | Genvec, Inc. | Methods and compositions for preserving adenoviral vectors |
| DK1421200T3 (da) * | 2001-08-23 | 2007-04-10 | Merck & Co Inc | Fluoprescerende multiplex HPV PCR-assays under anvendelse af flere fluoroforer |
| GB0222953D0 (en) * | 2002-10-03 | 2002-11-13 | Glaxo Group Ltd | Novel Compounds |
| EP1732598A4 (en) * | 2003-12-31 | 2009-08-26 | Pharmexa Inc | TRIGGERING CELLULAR IMMUNE RESPONSES TO THE HUMAN PAPILLOVIRUS USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS |
| PL1576967T3 (pl) * | 2004-03-18 | 2008-03-31 | Pasteur Institut | Rekombinowane białko niosące epitopy ludzkiego wirusa brodawczaka wstawione w białko cyklazy adenylanowej lub jego fragment oraz jego zastosowania terapeutyczne |
| EP2288380B1 (en) * | 2008-06-09 | 2020-06-03 | Bharat Biotech International Limited | Vaccine composition useful for hpv and hepatitis b infections and a method for preparing the same |
| US9050287B2 (en) * | 2009-01-23 | 2015-06-09 | The Trustees Of The University Of Pennsylvania | Vaccines for human papilloma virus and methods for using the same |
| KR102373828B1 (ko) * | 2011-10-12 | 2022-03-14 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 인간 파필로마 바이러스에 대한 백신 및 이것을 사용하는 방법 |
| WO2018060288A1 (en) * | 2016-09-29 | 2018-04-05 | Glaxosmithkline Biologicals S.A. | Compositions and methods of treatment of persistent hpv infection |
| WO2019151760A1 (ko) * | 2018-02-02 | 2019-08-08 | 주식회사 에스엘백시젠 | 신규 다가 hpv 백신 조성물 |
| SG11202008539YA (en) * | 2018-03-06 | 2020-10-29 | Precigen Inc | Human papillomavirus vaccines and uses of the same |
-
2021
- 2021-11-23 CA CA3197920A patent/CA3197920A1/en active Pending
- 2021-11-23 EP EP21899044.8A patent/EP4251278A4/en active Pending
- 2021-11-23 WO PCT/US2021/060605 patent/WO2022115470A1/en not_active Ceased
- 2021-11-23 KR KR1020237020302A patent/KR20230113331A/ko active Pending
- 2021-11-23 US US18/253,624 patent/US20240173396A1/en active Pending
- 2021-11-23 MX MX2023006038A patent/MX2023006038A/es unknown
- 2021-11-23 JP JP2023530809A patent/JP2023550480A/ja active Pending
- 2021-11-23 IL IL303113A patent/IL303113A/en unknown
- 2021-11-23 AU AU2021385551A patent/AU2021385551A1/en active Pending
- 2021-11-23 CN CN202180089584.2A patent/CN117203342A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2360001C2 (ru) | Оптимизированная экспрессия l1 hpv45 в дрожжах | |
| TWI744246B (zh) | 治療性hpv18疫苗 | |
| CA2011878C (en) | Immunogenic regions on the e7 protein of human papillomavirus type 16 | |
| JP4799789B2 (ja) | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 | |
| JP2007507207A5 (enExample) | ||
| CN101426811A (zh) | 基于hpv-16的乳头瘤病毒疫苗 | |
| CN101426810A (zh) | 基于hpv-18的乳头瘤病毒疫苗 | |
| US9249193B2 (en) | Truncated L1 protein of human papillomavirus type 33 | |
| IL215599A (en) | A nucleic acid-encoding vector for proteins 1e and 2e of the papilloma virus | |
| JP2018518172A5 (enExample) | ||
| JP2018518172A (ja) | Ｈｐｖワクチン | |
| JP2012509678A5 (enExample) | ||
| TW202043476A (zh) | 治療性hpv16疫苗 | |
| KR20100019432A (ko) | 다중 유전자 발현용 벡터 | |
| JP2011521985A (ja) | Ｈｃｖ感染の予防および治療のためのワクチン | |
| WO2024169804A1 (zh) | 一种基于Tac启动子的质粒表达载体构建及其用途 | |
| WO2014103608A1 (ja) | HPV/HBsキメラタンパク質を有効成分とするHPV感染症及び／又はＢ型肝炎用ワクチン | |
| CN102311500B (zh) | 一种抗病毒融合蛋白及其应用 | |
| JP2019502404A5 (enExample) | ||
| Gissmann et al. | Therapeutic vaccines for human papillomaviruses | |
| JP5545209B2 (ja) | 免疫原性を有する物質 | |
| CN116023446A (zh) | 人乳头瘤病毒hpv68 l1蛋白的表达和类病毒样颗粒及其制备方法 | |
| US6991795B1 (en) | Protein delivery system using human papillomavirus virus-like particles | |
| CN114127092B (zh) | 人乳头瘤病毒多价免疫原性组合物 | |
| AU753391B2 (en) | Protein delivery system using human papillomavirus virus-like particles |